Fundz

Menarini Group Appoints Thomas Cueni as New Director

PRIVATEMay 07, 2026

Position

Director

Company

Menarini Group

Thomas Cueni
BiotechnologyHealth CareMedicalTherapeuticsPharmaceutical

Description

The Menarini Group has strengthened its leadership by appointing Thomas Cueni as the new Director. Cueni brings nearly forty years of international experience in the pharmaceutical sector, enhancing the company's capability to tackle global health challenges.

Quick answer

Menarini Group Appoints Thomas Cueni as New Director (May 7, 2026).

Who is the new Director at Menarini Group?
Menarini Group named Thomas Cueni Director, announced May 7, 2026.
What did Menarini Group announce on May 7, 2026?
The Menarini Group has strengthened its leadership by appointing Thomas Cueni as the new Director. Cueni brings nearly forty years of international experience in the pharmaceutical sector, enhancing the company's capability to tackle global health challenges.
What does Menarini Group do?
Menarini Group is a leading international pharmaceutical and diagnostics company, dedicated to providing innovative solutions in oncology.
Which similar companies made leadership changes around the same time?
Radius (May 2, 2026), Juvisé Pharmaceuticals (April 16, 2026), NRx Pharmaceuticals (April 13, 2026) and Abivax (April 12, 2026) also announced leadership changes within 45 days of Menarini Group.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Menarini Group, and when

A new leader at Menarini Group brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Menarini Group raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Menarini Group, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Menarini Group. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Menarini Group

About

Menarini Group is a leading international pharmaceutical and diagnostics company, dedicated to providing innovative solutions in oncology. Its subsidiary, Stemline Therapeutics, focuses on transformative cancer treatments. The company is committed to advancing therapeutic options for patients with advanced or metastatic breast cancer. Menarini is known for its efforts in research and development in the field of oncology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Menarini Group changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Jorge
Likely contact at this company
••••••••@••••••••

See Jorge's verified email →

Arief
Likely contact at this company
••••••••@••••••••

See Arief's verified email →

Leonardo
Likely contact at this company
••••••••@••••••••

See Leonardo's verified email →

Herry
Likely contact at this company
••••••••@••••••••

See Herry's verified email →

Suniyatul
Likely contact at this company
••••••••@••••••••

See Suniyatul's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Menarini Group's next move

Learn about Strategic plan

Menarini Group changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.